New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 9, 2014
08:48 EDTBDSIBioDelivery Sciences price target raised to $18 from $13 at Ladenburg
Ladenburg raised its price target for BioDelivery Sciences shares to $18 after Bunavail received FDA approval for the maintenance treatment of opioid dependence. The firm keeps a Buy rating on the stock.
News For BDSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 28, 2014
08:04 EDTBDSIBioDelivery Sciences to develop opioid dependence injection with Evonik
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use